EVAX CSO Birgitte Rønø Appointed Dual Role as COO

Evaxion A/S announced that Birgitte Rønø, Chief Scientific Officer (CSO), will assume the dual role of CSO and Chief Operating Officer (COO). This expansion of her remit reflects an organizational alignment aimed at maximizing external engagement and strategy execution, particularly to enhance the visibility of Evaxion's AI-Immunology™ platform with partners and investors. The change also recognizes Dr. Rønø's extensive contributions to the company's internal operations. The management team remains composed of Helen Tayton-Martin (CEO), Birgitte Rønø (CSO & COO), Thomas Schmidt (CFO), and Andreas Mattsson (Chief AI Officer).